Descriptive Characterization of High-Frequency Distortion Product Otoacoustic Emission Source Components in Children.


Journal

Journal of speech, language, and hearing research : JSLHR
ISSN: 1558-9102
Titre abrégé: J Speech Lang Hear Res
Pays: United States
ID NLM: 9705610

Informations de publication

Date de publication:
03 08 2023
Historique:
pmc-release: 01 02 2024
medline: 4 8 2023
pubmed: 19 7 2023
entrez: 19 7 2023
Statut: ppublish

Résumé

Distortion product otoacoustic emissions (DPOAEs) provide an objective assessment of cochlear function and are used for serial ototoxicity monitoring in pediatric cancer patients. DPOAEs are modeled as having distortion (near DPOAEs were collected with varied frequency ratios ( Estimated peak pressures of DPOAE components revealed the greatest differences in DPOAE sources between children occurring at the highest frequencies tested, where the peak pressure of both components was largest for younger compared with older children. Latency differences between the children were only noted at higher frequencies for the distortion component. These results suggest that DPOAE levels decrease with age and reflection emissions are vulnerable to cochlear change. This work guides optimization of protocols for pediatric ototoxicity monitoring, whereby including EHF otoacoustic emissions is clearly warranted and choosing to isolate DPOAE sources may prove beneficial. https://doi.org/10.23641/asha.23669214.

Identifiants

pubmed: 37467378
doi: 10.1044/2023_JSLHR-23-00013
pmc: PMC10555457
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2950-2966

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC017867
Pays : United States

Références

J Acoust Soc Am. 2001 Jun;109(6):2862-79
pubmed: 11425129
J Acoust Soc Am. 2015 Dec;138(6):3785-99
pubmed: 26723333
J Assoc Res Otolaryngol. 2012 Jun;13(3):403-21
pubmed: 22476702
Int J Audiol. 2007 Aug;46(8):419-26
pubmed: 17654083
J Acoust Soc Am. 1991 Apr;89(4 Pt 1):1749-59
pubmed: 2045583
Noise Health. 2013 Sep-Oct;15(66):315-25
pubmed: 23955128
Hear Res. 1984 Jan;13(1):29-37
pubmed: 6706860
Ear Hear. 2012 May-Jun;33(3):315-29
pubmed: 22436407
Ear Hear. 2018 Jan/Feb;39(1):85-100
pubmed: 28678077
J Acoust Soc Am. 1998 Aug;104(2 Pt 1):964-71
pubmed: 9714916
J Acoust Soc Am. 1996 Feb;99(2):1016-24
pubmed: 8609284
J Acoust Soc Am. 2003 May;113(5):2762-72
pubmed: 12765394
Otol Neurotol. 2016 Sep;37(8):e286-94
pubmed: 27518137
Hear Res. 2001 May;155(1-2):1-8
pubmed: 11335071
J Assoc Res Otolaryngol. 2022 Oct;23(5):647-664
pubmed: 35804277
Otolaryngol Pol. 2004;58(1):131-8
pubmed: 15101272
Ear Hear. 2022 Nov-Dec 01;43(6):1824-1835
pubmed: 35853351
Ear Hear. 1999 Oct;20(5):393-402
pubmed: 10526861
Ear Hear. 2020 Mar/Apr;41(2):239-253
pubmed: 29280917
J Acoust Soc Am. 1995 Oct;98(4):2018-47
pubmed: 7593924
Noise Health. 2015 Sep-Oct;17(78):263-72
pubmed: 26356368
Hear Res. 1994 Nov;80(2):146-52
pubmed: 7896573
Hear Res. 2022 Jun;419:108207
pubmed: 33674070
J Acoust Soc Am. 1996 Mar;99(3):1573-87
pubmed: 8819854
J Acoust Soc Am. 2001 Feb;109(2):622-37
pubmed: 11248969
J Acoust Soc Am. 2014 Oct;136(4):1768-87
pubmed: 25324079
J Acoust Soc Am. 1989 Jan;85(1):220-9
pubmed: 2921404
J Acoust Soc Am. 2005 May;117(5):2980-8
pubmed: 15957768
Laryngoscope. 1955 Jun;65(6):402-19
pubmed: 14392966
J Acoust Soc Am. 2001 Nov;110(5 Pt 1):2456-69
pubmed: 11757935
J Acoust Soc Am. 2014 Jan;135(1):287-99
pubmed: 24437769
Lancet Child Adolesc Health. 2020 Feb;4(2):141-150
pubmed: 31866182
J Acoust Soc Am. 1990 Aug;88(2):840-9
pubmed: 2212309
J Acoust Soc Am. 2000 Jan;107(1):457-73
pubmed: 10641654
J Acoust Soc Am. 1999 Feb;105(2 Pt 1):782-98
pubmed: 9972564
Ear Hear. 2004 Dec;25(6):554-64
pubmed: 15604916
Ear Hear. 2006 Oct;27(5):466-79
pubmed: 16957498
Ear Hear. 2015 Sep-Oct;36(5):e251-60
pubmed: 25985018
JAMA Oncol. 2021 Oct 01;7(10):1550-1558
pubmed: 34383016
J Acoust Soc Am. 2010 Jan;127(1):316-25
pubmed: 20058979
Ear Hear. 1990 Aug;11(4):247-56
pubmed: 2210098
J Acoust Soc Am. 1999 Jan;105(1):275-92
pubmed: 9921655
J Acoust Soc Am. 2011 Feb;129(2):792-800
pubmed: 21361438

Auteurs

Laura Dreisbach (L)

School of Speech, Language, and Hearing Sciences, San Diego State University, CA.

Dawn Konrad-Martin (D)

National Center for Rehabilitative Auditory Research, VA Portland Health Care System, OR.

Christine Gagner (C)

School of Speech, Language, and Hearing Sciences, San Diego State University, CA.

Kelly M Reavis (KM)

National Center for Rehabilitative Auditory Research, VA Portland Health Care System, OR.
OHSU-PSU School of Public Health, Oregon Health & Science University, Portland.

Peter G Jacobs (PG)

Department of Biomedical Engineering, Oregon Health & Science University, Portland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH